White I M, Flory G S, Hooper K C, Speciale J, Banks D A, Rebec G V
Program in Neural Science, Department of Psychology, Indiana University, Bloomington, USA.
J Neural Transm Gen Sect. 1995;102(2):99-112. doi: 10.1007/BF01276506.
Amphetamine and related drugs of abuse facilitate dopamine transmission in the striatum. This action is believed to underlie the increase in firing of striatal motor-related neurons after amphetamine administration in behaving rats. The present study extended this electrophysiological investigation to phencyclidine (PCP), a nonamphetamine psychomotor stimulant that acts primarily as a noncompetitive antagonist of N-methyl-D-aspartate (NMDA) glutamate receptors. Like amphetamine, PCP (1.0, 2.5, or 5.0 mg/kg) increased the activity of striatal motor-related neurons concomitant with behavioral activation. These effects were blocked by subsequent administration of either 1.0 mg/kg haloperidol or 20.0 mg/kg clozapine, typical and atypical neuroleptics, respectively. Dizocilpine (MK- 801), another noncompetitive NMDA antagonist, mimicked the effect of PCP. Collectively, these results indicate that amphetamine and NMDA antagonists exert comparable effects on striatal motor-related neurons, suggesting that the response of these cells to psychomotor stimulants is regulated by a dopaminergic-glutamatergic influence.
苯丙胺及相关滥用药物可促进纹状体中的多巴胺传递。这种作用被认为是导致在行为学实验大鼠中给予苯丙胺后纹状体运动相关神经元放电增加的原因。本研究将这一电生理研究扩展至苯环利定(PCP),一种非苯丙胺类精神运动兴奋剂,其主要作为N-甲基-D-天冬氨酸(NMDA)谷氨酸受体的非竞争性拮抗剂起作用。与苯丙胺一样,PCP(1.0、2.5或5.0 mg/kg)增加了纹状体运动相关神经元的活动,同时伴有行为激活。随后分别给予1.0 mg/kg氟哌啶醇或20.0 mg/kg氯氮平(典型和非典型抗精神病药物)可阻断这些效应。另一种非竞争性NMDA拮抗剂地佐环平(MK-801)模拟了PCP的作用。总体而言,这些结果表明苯丙胺和NMDA拮抗剂对纹状体运动相关神经元具有类似的作用,提示这些细胞对精神运动兴奋剂的反应受多巴胺能-谷氨酸能影响的调节。